UBS Group AG - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 28 filers reported holding KURA ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$750,986
+417114.4%
82,345
+484282.4%
0.00%
Q2 2023$180
-100.0%
17
-100.0%
0.00%
-100.0%
Q1 2023$2,618,932
-1.8%
214,140
-0.4%
0.00%0.0%
Q4 2022$2,667,356
+487.5%
214,936
+546.8%
0.00%
Q3 2022$454,000
-59.6%
33,231
-45.7%
0.00%
Q2 2022$1,123,000
-63.0%
61,248
-67.6%
0.00%
-100.0%
Q1 2022$3,036,000
+31.6%
188,819
+14.6%
0.00%0.0%
Q4 2021$2,307,000
+978.0%
164,807
+1340.1%
0.00%
Q3 2021$214,000
-24.6%
11,444
-15.9%
0.00%
Q2 2021$284,000
-82.7%
13,603
-76.5%
0.00%
-100.0%
Q1 2021$1,640,000
+619.3%
57,999
+730.1%
0.00%
Q4 2020$228,000
+31.8%
6,987
+24.0%
0.00%
Q3 2020$173,000
+4225.0%
5,634
+2162.7%
0.00%
Q2 2020$4,000
-97.6%
249
-98.5%
0.00%
Q1 2020$165,000
-61.5%
16,550
-46.9%
0.00%
Q4 2019$429,000
-64.1%
31,169
-60.4%
0.00%
Q3 2019$1,194,000
+3311.4%
78,669
+4390.2%
0.00%
Q2 2019$35,000
-95.0%
1,752
-96.5%
0.00%
Q4 2018$705,000
+477.9%
50,275
+618.8%
0.00%
Q3 2018$122,000
-78.8%
6,994
-77.2%
0.00%
Q1 2018$575,000
+201.0%
30,671
+145.4%
0.00%
Q4 2017$191,000
-15.9%
12,500
-17.8%
0.00%
Q3 2017$227,000
+887.0%
15,204
+476.1%
0.00%
Q1 2017$23,000
+130.0%
2,639
+49.3%
0.00%
Q4 2016$10,000
-56.5%
1,767
-51.3%
0.00%
Q3 2016$23,000
+360.0%
3,631
+206.7%
0.00%
Q1 2016$5,0001,1840.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2016
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders